Title : Biochemical modulation of arabinosylcytosine for therapy of leukemias.

Pub. Date : 1993

PMID : 8481660






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Analysis of different ribonucleotide reductase inhibitors to modulate arabinosylcytosine (ara-C) metabolism suggested that pretreatment with arabinosyl-2-fluoroadenine (F-ara-A) significantly potentiated the rate of ara-CTP (5"-triphosphate of ara-C) accumulation in both quiescent lymphocytes (p = 0.046) and in cycling blasts (p = 0.017). fludarabine solute carrier family 25 member 1 Homo sapiens
2 In vitro incubations of freshly isolated leukemia cells from patients with chronic (n = 7) or acute (n = 5) leukemias with F-ara-A, increased the rate of ara-CTP accumulation by a median of 1.5 or 1.7-fold, respectively, when subsequently incubated with ara-C. fludarabine solute carrier family 25 member 1 Homo sapiens
3 Comparison of ara-CTP pharmacokinetics demonstrated a significant increase in the area under concentration curve (AUC) of ara-CTP both in CLL (median 1.5-fold) and AML cells (median 1.8-fold) after fludarabine infusion. fludarabine solute carrier family 25 member 1 Homo sapiens
4 Comparison of ara-CTP pharmacokinetics demonstrated a significant increase in the area under concentration curve (AUC) of ara-CTP both in CLL (median 1.5-fold) and AML cells (median 1.8-fold) after fludarabine infusion. fludarabine solute carrier family 25 member 1 Homo sapiens